{
    "2020-09-18": [
        [
            {
                "time": "",
                "original_text": "每日医药资讯：甘李药业甘精胰岛素在哈萨克斯坦获批、复星医药附属拟斥资450万元收购易研云",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "甘精胰岛素",
                        "哈萨克斯坦",
                        "获批",
                        "复星医药",
                        "收购",
                        "易研云"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业甘精胰岛素在哈萨克斯坦获批 加速全球市场扩张",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "甘精胰岛素",
                        "哈萨克斯坦",
                        "获批",
                        "全球市场",
                        "扩张"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}